Effect of camptothecin on the proliferation and apoptosis of HeLa cells

ZHAO Xing-yu ZHAO Rong TIAN Feng-yu HOU Jian-cheng ZHANG Wei

Acta Anatomica Sinica ›› 2018, Vol. 49 ›› Issue (4) : 450-454.

PDF(517 KB)
Welcome to visit Acta Anatomica Sinica! Today is Chinese
PDF(517 KB)
Acta Anatomica Sinica ›› 2018, Vol. 49 ›› Issue (4) : 450-454. DOI: 10.16098/j.issn.0529-1356.2018.04.006
Cancer Biology

Effect of camptothecin on the proliferation and apoptosis of HeLa cells

  • ZHAO Xing-yu ZHAO Rong TIAN Feng-yu HOU Jian-cheng ZHANG Wei*
Author information +
History +

Abstract

Objective  To study the effect of different concentrations of camptothecin(CPT) on the apoptosis of human cervical cancer cells (HeLa), and to explore the mechanism of apoptosis induced by CPT in HeLa cells. Methods  The cultured in vitro human cervical cancer cells (HeLa) were divided into the control group and CPT groups treated with various concentrations(100 nmol/L-10 μmol/L). The viability of HeLa cells were detected by methyl thiazolyl tetrazolium (MTT) assay. The morphology changes of HeLa cells were observed with an inverted microscope. The cells apoptosis was analyzed by 4’6-diamidino-2-phenylindole(DAPI) and flow cytometry (FCM). Western blotting was used to detect the expression of Bcl-2, Bax,Cleave-Caspase-3,Cyt-C and poly ADP-ribose polymerase(PARP). Results  Compared with the control group, the viability of HeLa cells decreased after treatment with different concentrations of CPT for 24 hours, and the cells morphology was changed in a dose-dependent manner. DAPI dying showed that there were apoptotic bodies FCM assay indicated that the early apoptosis ratios was increased after treatment with different concentrations of CPT for 24 hours. The cell apoptotic rate increased obviously in the CPT-treated groups than in the control group. The expression of Bcl-2 was decreased whereas the expressions of Bax,cleave-Caspase-3, Cyt-C into cell plasm and 89 kD phosphoribosyl pyrophosphate(PRPP) were increased when compared to that in the control group. Conclusion  CPT can induce HeLa cell apoptosis, and its mechanism may be to activate the mitochondrial dependent pathway, and further activate substrate PARP.

Key words

Camptothcin / Cell proliferation / HeLa cell / Western blotting / Human

Cite this article

Download Citations
ZHAO Xing-yu ZHAO Rong TIAN Feng-yu HOU Jian-cheng ZHANG Wei. Effect of camptothecin on the proliferation and apoptosis of HeLa cells[J]. Acta Anatomica Sinica. 2018, 49(4): 450-454 https://doi.org/10.16098/j.issn.0529-1356.2018.04.006

References

[1] Gonzaleal MA,Tin A. Molecular biology of cervical cancer[J]. Clin Transl Oncol,2007,9(6):347-354.
[2] Li F, Jiang T, Li Q,et al.. Camptothecin (CPT) and its derivatives are known to target topoisomerase Ⅰ (TopⅠ) as their mechanism of action: did we miss something in CPT analogue molecular targets for treating human disease such as cancer [J]? Am J Cancer Res, 2017, 7(12): 2350-2394.
[3] Mathijssen RH, Loos WJ, Verweij J, et al. Pharmacology of topoisomerase Ⅰ inhibitors irinotecan (CPT-11) and topotecan[J]. Curr Cancer Drug Targets, 2002, 2(2): 103-123.
[4] Fu YR, Yi ZJ, Yan YR, et al. Changes in the protein spectrum of mitochondria isolated from hydroxycamptothecin-treated hepatoma cells[J]. Anticancer Drugs, 2007, 18(9): 1045-1052.
[5] Wu MY, Wang SF, Cai CZ,et al. Natural autophagy blockers, dauricine (DAC) and daurisoline (DAS), sensitize cancer cells to camptothecin-induced toxicity [J]. Oncotarget,  2017, 8(44):77673-77684.
[6] Lin J,Wang X.The synergistic antitumor effects of berberine α-hydroxy-β-decanoylethylsulfonate with hydroxycamptothecine and its effect on topoisomerase[J]. Acta Pharmaceutica Sinica, 2011, 46 (4): 390-394.
[7] Debatin KM, Krammer PH. Death receptors in chemotherapy and cancer[J]. Oncogene, 2004, 23(16): 2950-2966.
[8] Jun HS, Park T, Lee CK, et al. Capsaicin induced apoptosis of B16-F10 melanoma cells through downregulation of Bcl-2[J]. Food Chem Toxicol, 2007, 45(5): 708-715.
[9] Goldsmith KC, Hogarty MD. Targeting programmed cell death pathways with experimental therapeutics: opportunities in high-risk neuroblastoma[J]. Cancer Lett, 2005, 228(1-2): 133-141.
[10] Hu W, Zhang C, Fang Y, et al. Anticancer properties of 10-hydroxycamptothecin in a murine melanoma pulmonary metastasis model in vitro and in vivo[J]. Toxicol In Vitro, 2011, 25(2): 513-520.
[11] Fulda S. Apoptosis pathways and neuroblastoma therapy[J]. Curr Pharm Des, 2009, 15(4): 430-435.
[12] Khageh Hosseini S, Kolterer S, Steiner M,et al. Camptothecin and its analog SN-38, the active metabolite of irinotecan, inhibit binding of the transcriptional regulator and oncoprotein FUBP1 to its DNA target sequence FUSE [J]. Biochem Pharmacol, 2017, 146(1):53-62.
[13] Roy AM, Baliga MS, Elmets CA, et al. Grape seed proanthocyanidins induce apoptosis through p53, Bax, and caspase 3 pathways[J]. Neoplasia, 2005, 7(1): 24-36.
PDF(517 KB)

Accesses

Citation

Detail

Sections
Recommended

/